Jazz Pharmaceuticals plc — Director's Dealing 2014

Jun 11, 2014

SEC Form 4/A — Form 4/A

Issuer: Jazz Pharmaceuticals plc (JAZZ)
CIK: 0001232524
Period of Report: 2014-06-09

Reporting Person: Keegan Fintan (EVP, Technical Operations)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-06-09	Ordinary Shares	S	750	$146.24	Disposed	37022	Direct

Footnotes

F1: The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person

F2: The Reporting Person's original Form 4 incorrectly described the reported transaction by using Transaction Code "U" to describe such transaction. The Transaction Code that most accurately describes the reported transaction is Transaction Code "S", and this amended Form 4 is being filed to reflect the correct Transaction Code.